K
Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
TSX:GUD
Price:
5.77 CAD
Updated:
May 2, 2024
Knight Therapeutics Inc
Net Income (Common)
|
Knight Therapeutics Inc
Net Income (Common) Peer Comparison
Comparables:
BHC
WEED
CRON
C
CURA
T
TER
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Net Income (Common)
-CA$16.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Net Income (Common)
-$592m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
32%
|
CAGR 10-Years
4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Net Income (Common)
-CA$1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Net Income (Common)
-$74m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Net Income (Common)
-$588.1m
|
CAGR 3-Years
-124%
|
CAGR 5-Years
-347%
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Net Income (Common)
-$329.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Knight Therapeutics Inc's Net Income (Common)?
Net Income (Common)
-16.8m
CAD
-16.8m
CAD
Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Net Income (Common) amounts to -16.8m CAD.
What is Knight Therapeutics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
44%
44%
Over the last year, the Net Income (Common) growth was 44%.
You don't have any saved screeners yet
